#166: Adam Graybill (Journey Biosciences) — Shifting the Future of Diabetes & Care Lay of The Land

Adam Graybill, co-founder and CEO of Journey Biosciences.
With a robust 20-year tenure in the diabetes market, Adam has been at the forefront of assembling purpose-driven teams and forging impactful strategic partnerships across the healthcare landscape; having played an instrumental role in building the Cardinal Health At Home business to a billion-plus dollar entity, ultimately serving over 300,000 individuals with type 1 diabetes each year.
Deeply understanding of the demands and burden that come with managing a chronic condition, like a diabetes diagnosis, Adam co-founded Journey Biosciences with Dr. Paul Beisswenger to positively impact the >20 million diabetes patients in the US, and ~37 million Americans who suffer from chronic kidney disease.
Journey Biosciences has launched the first predictive screening for people with diabetes that identifies patients at risk of chronic kidney disease before any clinical signs or symptoms, allowing clinicians to then take swift, targeted action with intensive interventions, resulting in life-saving and cost-saving benefits. Technically NaviDKD is Journey Bioscience’s clinically validated and CPT code-certified screening for adult diabetes patients — it utilizes measurements of AGEs, A1C, eGFR, and other personal information — providing insight into long-term complications of diabetes, blood glucose levels over time, and overall kidney function — to stratify individuals into three distinct risk categories
This was an awesome conversation — Adam is incredibly passionate about meliorating the lives of individuals affected by chronic health conditions and it was inspiring to hear how he’s built Journey Biosciences to that end. We cover his motivations, doing the work you're meant to be doing, the journey of Journey Biosciences, and a whole lot more!
-----
LINKS:https://www.linkedin.com/in/adamgraybill/https://www.journeybio.life/https://www.instagram.com/journeybio.life/https://twitter.com/journeybio
-----
SPONSORS: John Carroll University Boler College of Business || Impact Architects & Ninety
John Carroll University Boler College of Business: https://business.jcu.edu/ As we’ve heard time and time again from entrepreneurs on Lay of The Land — many of whom are proud alumni of John Carroll University —  success in this ever-changing world of business requires a dynamic and innovative mindset, deep understanding of emerging technology and systems, strong ethics, leadership prowess, acute business acumen… all qualities nurtured through the Boler College of Business!
With 4 different MBA programs of study — spanning Professional, Online, Hybrid, and 1-Year-Flexible — The Boler College of Business provides flexible timelines and various class structures for each MBA Track — including online, in-person, hybrid and asynchronous — to offer the most effective options for you, in addition to the ability to participate in an elective International Study Tour, providing unparalleled opportunities to expand your global business knowledge by networking with local companies overseas and experiencing a new culture.
The career impact of a Boler MBA is formative and will help prepare you for this future of business and get more out of your career. To learn more about John Carroll University’s Boler MBA programs, please go to business.jcu.edu
The Boler College of Business is fully accredited by AACSB International, the highest accreditation a College of Business can have.
Impact Architects & NinetyLay of The Land is brought to you by Ninety. As a Lay of The Land listener, you can leverage a free trial with Ninety, the platform that helps teams build great companies and the only officially licensed software for EOS® — used by over 7,000 companies and 100,000 users!
This episode is brought to you by Impact Architects. As we share the stories of entrepreneurs building incredible organizations throughout NEO, Impact Architects helps those leaders — many of whom we’ve